cycle like what we saw in IDEO and its design thinking approach? 2. How much can you compress the vaccine development timeline? What steps do you have to take to achieve this? What risks do you take on if you try this? 3. Pharma companies, Merck included, do a lot of acquisitions. In this context of the innovation funnel, why would you do that? 4. Consider Exhibit 11 and try to develop a quantitative feel for factors that drive the selection of cohort size for a randomized control trial (RCT) for a new Covid-19 vaccine. What would you look for? Would China be a good place to conduct RCT? Spain? What part of the U.S.? 5. What should Ken Frazier do with respect to the OWS funding? Should Merck seek or accept money from BARDA? What factors should Merck consider in making this decision? For reference, a selected comparison for the U.S. CDC pediatric vaccine price list and the GAVI price list for the developing world follows: cycle like what we saw in IDEO and its design thinking approach? 2. How much can you compress the vaccine development timeline? What steps do you have to take to achieve this? What risks do you take on if you try this? 3. Pharma companies, Merck included, do a lot of acquisitions. In this context of the innovation funnel, why would you do that? 4. Consider Exhibit 11 and try to develop a quantitative feel for factors that drive the selection of cohort size for a randomized control trial (RCT) for a new Covid-19 vaccine. What would you look for? Would China be a good place to conduct RCT? Spain? What part of the U.S.? 5. What should Ken Frazier do with respect to the OWS funding? Should Merck seek or accept money from BARDA? What factors should Merck consider in making this decision? For reference, a selected comparison for the U.S. CDC pediatric vaccine price list and the GAVI price list for the developing world follows